Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Amniotic membrane transplantation in ocular surface disorders.

Gian Marco Tosi1, Mina Massaro-Giordano, Aldo Caporossi

  • 1Department of Ophthalmology and Neurosurgery, University of Siena, Siena, Italy.

Journal of Cellular Physiology
|October 14, 2004
PubMed
Summary

Amniotic membrane transplantation (AMT) offers hope for chronic ocular surface disorders by promoting epithelial growth and reducing inflammation. Further research is needed to fully understand its long-term mechanisms and optimize its use in tissue and cell therapy.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Accuracy of template-guided zygomatic implant placement: a retrospective case series using cone-beam computed tomography.

Oral and maxillofacial surgery·2026
Same author

Automated iridocorneal angle classification using a multimodal large language model.

Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie·2026
Same author

Rational design of hammerhead ribozymes as CD93 silencing tools for vascular diseases.

Molecular therapy. Nucleic acids·2026
Same author

Buccal bone plate stability after immediate implant placement and loading: A 10-year radiographic evaluation.

Journal of stomatology, oral and maxillofacial surgery·2026
Same author

Sponge-assisted intracameral length titration: a new technical modification for Ab externo XEN implantation.

Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie·2026
Same author

Morphological characteristics of graft-host interface after ultra thin Descemet stripping automated endothelial keratoplasty (UT-DSAEK): impact of Descemetorhexis technique assessed by in vivo confocal microscopy (IVCM) and anterior segment optical coherence tomography (AS-OCT).

BMC ophthalmology·2026

Area of Science:

  • Ophthalmology
  • Regenerative Medicine
  • Tissue Engineering

Background:

  • Chronic ocular surface disorders were historically considered untreatable, causing significant functional impairment.
  • Amniotic membrane transplantation (AMT), reintroduced in 1995, emerged as a promising tissue and cell therapy strategy.
  • Amniotic membrane (AM) demonstrates therapeutic potential through epithelial support, anti-inflammatory, anti-scarring, and antimicrobial properties.

Purpose of the Study:

  • To review the therapeutic mechanisms and clinical efficacy of amniotic membrane transplantation (AMT) for ocular surface disorders.
  • To highlight the role of AM as a substrate for ocular surface epithelial growth and ex vivo cell expansion.
  • To identify current uncertainties regarding the fate and long-term effects of grafted AM.

Main Methods:

Related Experiment Videos

  • Review of existing literature on amniotic membrane transplantation (AMT) for ocular surface disorders.
  • Analysis of the biological properties of amniotic membrane (AM) relevant to ocular surface repair.
  • Discussion of clinical applications and ongoing research into the mechanisms of AM therapy.

Main Results:

  • AMT, alone or with limbal stem cell transplantation, shows clinical efficacy in treating ocular surface disorders.
  • AM acts as a biological scaffold, promotes epithelial regeneration, and possesses anti-inflammatory and antimicrobial functions.
  • AM is utilized for ex vivo expansion of corneal epithelial cells for ocular surface reconstruction.

Conclusions:

  • While clinical efficacy of AMT is widely recognized, the precise fate and long-term mechanisms of grafted AM remain unclear.
  • Further controlled clinical trials are essential to determine specific indications for AMT and elucidate its interaction with ocular mediators for optimal reconstruction.
  • Understanding these mechanisms will refine the application of AM in tissue and cell therapy for ocular surface repair.